Forskning ved Københavns Universitet - Københavns Universitet

Forside

Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. / Frederiksen, B.; Specht, L.; Henrichsen, J.; Pedersen, F.K.; Pedersen-Bjergaard, J.

I: European Journal of Haematology, Bind 43, Nr. 1, 1989, s. 45-49.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Frederiksen, B, Specht, L, Henrichsen, J, Pedersen, FK & Pedersen-Bjergaard, J 1989, 'Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease', European Journal of Haematology, bind 43, nr. 1, s. 45-49.

APA

Frederiksen, B., Specht, L., Henrichsen, J., Pedersen, F. K., & Pedersen-Bjergaard, J. (1989). Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. European Journal of Haematology, 43(1), 45-49.

Vancouver

Frederiksen B, Specht L, Henrichsen J, Pedersen FK, Pedersen-Bjergaard J. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. European Journal of Haematology. 1989;43(1):45-49.

Author

Frederiksen, B. ; Specht, L. ; Henrichsen, J. ; Pedersen, F.K. ; Pedersen-Bjergaard, J. / Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. I: European Journal of Haematology. 1989 ; Bind 43, Nr. 1. s. 45-49.

Bibtex

@article{562235b04c8811df928f000ea68e967b,
title = "Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease",
abstract = "Antibody response to pneumococcal vaccination was studied in 76 patients with Hodgkin's disease (HD) before, during and at different time intervals after cessation of therapy. All patients were in pathological stage I and II following explorative laparatomy with splenectomy. The increase in antibody response was compared to the findings in 12 healthy volunteers with the aim of establishing the optimal time for vaccination. Serum antibodies against 6 of the pneumococcal polysaccharide antigens (types 1, 4, 7F, 14, 18C and 23F) contained in the vaccine were determined by an ELISA. Antibody response to pneumococcal type antigens was similar in healthy adults and in patients with early stage HD before therapy. After treatment, postvaccination antibody response became negligible. Even up to 7 years after cessation of therapy patients were not able to raise a significant antibody response Udgivelsesdato: 1989/7",
author = "B. Frederiksen and L. Specht and J. Henrichsen and F.K. Pedersen and J. Pedersen-Bjergaard",
note = "DA - 19890928IS - 0902-4441 (Print)LA - engPT - Journal ArticlePT - Research Support, Non-U.S. Gov'tRN - 0 (Antibodies, Bacterial)RN - 0 (Antigens, Bacterial)RN - 0 (Bacterial Vaccines)SB - IM",
year = "1989",
language = "Dansk",
volume = "43",
pages = "45--49",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease

AU - Frederiksen, B.

AU - Specht, L.

AU - Henrichsen, J.

AU - Pedersen, F.K.

AU - Pedersen-Bjergaard, J.

N1 - DA - 19890928IS - 0902-4441 (Print)LA - engPT - Journal ArticlePT - Research Support, Non-U.S. Gov'tRN - 0 (Antibodies, Bacterial)RN - 0 (Antigens, Bacterial)RN - 0 (Bacterial Vaccines)SB - IM

PY - 1989

Y1 - 1989

N2 - Antibody response to pneumococcal vaccination was studied in 76 patients with Hodgkin's disease (HD) before, during and at different time intervals after cessation of therapy. All patients were in pathological stage I and II following explorative laparatomy with splenectomy. The increase in antibody response was compared to the findings in 12 healthy volunteers with the aim of establishing the optimal time for vaccination. Serum antibodies against 6 of the pneumococcal polysaccharide antigens (types 1, 4, 7F, 14, 18C and 23F) contained in the vaccine were determined by an ELISA. Antibody response to pneumococcal type antigens was similar in healthy adults and in patients with early stage HD before therapy. After treatment, postvaccination antibody response became negligible. Even up to 7 years after cessation of therapy patients were not able to raise a significant antibody response Udgivelsesdato: 1989/7

AB - Antibody response to pneumococcal vaccination was studied in 76 patients with Hodgkin's disease (HD) before, during and at different time intervals after cessation of therapy. All patients were in pathological stage I and II following explorative laparatomy with splenectomy. The increase in antibody response was compared to the findings in 12 healthy volunteers with the aim of establishing the optimal time for vaccination. Serum antibodies against 6 of the pneumococcal polysaccharide antigens (types 1, 4, 7F, 14, 18C and 23F) contained in the vaccine were determined by an ELISA. Antibody response to pneumococcal type antigens was similar in healthy adults and in patients with early stage HD before therapy. After treatment, postvaccination antibody response became negligible. Even up to 7 years after cessation of therapy patients were not able to raise a significant antibody response Udgivelsesdato: 1989/7

M3 - Tidsskriftartikel

VL - 43

SP - 45

EP - 49

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 1

ER -

ID: 19371443